Medical Care

Global Chimeric Antigen Receptor T Cell Therapy Market Research Report 2025

The global market for Chimeric Antigen Receptor T Cell Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Chimeric Antigen Receptor T Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Chimeric Antigen Receptor T Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Chimeric Antigen Receptor T Cell Therapy in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Chimeric Antigen Receptor T Cell Therapy include Amgen, Bellicum Pharmaceuticals, Bluebird Bio, Caribou Biosciences, Celgene Corporation, Cellectis, Celyad Oncology, Gilead Sciences, Intellia Therapeutics, Johnson & Johnson, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chimeric Antigen Receptor T Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chimeric Antigen Receptor T Cell Therapy.
The Chimeric Antigen Receptor T Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chimeric Antigen Receptor T Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chimeric Antigen Receptor T Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Bellicum Pharmaceuticals
Bluebird Bio
Caribou Biosciences
Celgene Corporation
Cellectis
Celyad Oncology
Gilead Sciences
Intellia Therapeutics
Johnson & Johnson
Legend Biotech
Merck
Noile-Immune Biotech
Novartis
Pfizer
Sangamo Therapeutics
Servier Laboratories
Segment by Type
Allogeneic
Autologous
Segment by Application
Hospitals
Universities and Colleges
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chimeric Antigen Receptor T Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Allogeneic
1.2.3 Autologous
1.3 Market by Application
1.3.1 Global Chimeric Antigen Receptor T Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Universities and Colleges
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chimeric Antigen Receptor T Cell Therapy Market Perspective (2020-2031)
2.2 Global Chimeric Antigen Receptor T Cell Therapy Growth Trends by Region
2.2.1 Global Chimeric Antigen Receptor T Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chimeric Antigen Receptor T Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Chimeric Antigen Receptor T Cell Therapy Market Dynamics
2.3.1 Chimeric Antigen Receptor T Cell Therapy Industry Trends
2.3.2 Chimeric Antigen Receptor T Cell Therapy Market Drivers
2.3.3 Chimeric Antigen Receptor T Cell Therapy Market Challenges
2.3.4 Chimeric Antigen Receptor T Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chimeric Antigen Receptor T Cell Therapy Players by Revenue
3.1.1 Global Top Chimeric Antigen Receptor T Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Chimeric Antigen Receptor T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chimeric Antigen Receptor T Cell Therapy Revenue
3.4 Global Chimeric Antigen Receptor T Cell Therapy Market Concentration Ratio
3.4.1 Global Chimeric Antigen Receptor T Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor T Cell Therapy Revenue in 2024
3.5 Global Key Players of Chimeric Antigen Receptor T Cell Therapy Head office and Area Served
3.6 Global Key Players of Chimeric Antigen Receptor T Cell Therapy, Product and Application
3.7 Global Key Players of Chimeric Antigen Receptor T Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chimeric Antigen Receptor T Cell Therapy Breakdown Data by Type
4.1 Global Chimeric Antigen Receptor T Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Chimeric Antigen Receptor T Cell Therapy Breakdown Data by Application
5.1 Global Chimeric Antigen Receptor T Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chimeric Antigen Receptor T Cell Therapy Market Size (2020-2031)
6.2 North America Chimeric Antigen Receptor T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2020-2025)
6.4 North America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chimeric Antigen Receptor T Cell Therapy Market Size (2020-2031)
7.2 Europe Chimeric Antigen Receptor T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chimeric Antigen Receptor T Cell Therapy Market Size (2020-2031)
9.2 Latin America Chimeric Antigen Receptor T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Chimeric Antigen Receptor T Cell Therapy Introduction
11.1.4 Amgen Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.1.5 Amgen Recent Development
11.2 Bellicum Pharmaceuticals
11.2.1 Bellicum Pharmaceuticals Company Details
11.2.2 Bellicum Pharmaceuticals Business Overview
11.2.3 Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Introduction
11.2.4 Bellicum Pharmaceuticals Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.2.5 Bellicum Pharmaceuticals Recent Development
11.3 Bluebird Bio
11.3.1 Bluebird Bio Company Details
11.3.2 Bluebird Bio Business Overview
11.3.3 Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Introduction
11.3.4 Bluebird Bio Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.3.5 Bluebird Bio Recent Development
11.4 Caribou Biosciences
11.4.1 Caribou Biosciences Company Details
11.4.2 Caribou Biosciences Business Overview
11.4.3 Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Introduction
11.4.4 Caribou Biosciences Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.4.5 Caribou Biosciences Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Introduction
11.5.4 Celgene Corporation Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.5.5 Celgene Corporation Recent Development
11.6 Cellectis
11.6.1 Cellectis Company Details
11.6.2 Cellectis Business Overview
11.6.3 Cellectis Chimeric Antigen Receptor T Cell Therapy Introduction
11.6.4 Cellectis Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.6.5 Cellectis Recent Development
11.7 Celyad Oncology
11.7.1 Celyad Oncology Company Details
11.7.2 Celyad Oncology Business Overview
11.7.3 Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Introduction
11.7.4 Celyad Oncology Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.7.5 Celyad Oncology Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Introduction
11.8.4 Gilead Sciences Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.8.5 Gilead Sciences Recent Development
11.9 Intellia Therapeutics
11.9.1 Intellia Therapeutics Company Details
11.9.2 Intellia Therapeutics Business Overview
11.9.3 Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Introduction
11.9.4 Intellia Therapeutics Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.9.5 Intellia Therapeutics Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Introduction
11.10.4 Johnson & Johnson Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.10.5 Johnson & Johnson Recent Development
11.11 Legend Biotech
11.11.1 Legend Biotech Company Details
11.11.2 Legend Biotech Business Overview
11.11.3 Legend Biotech Chimeric Antigen Receptor T Cell Therapy Introduction
11.11.4 Legend Biotech Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.11.5 Legend Biotech Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Chimeric Antigen Receptor T Cell Therapy Introduction
11.12.4 Merck Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.12.5 Merck Recent Development
11.13 Noile-Immune Biotech
11.13.1 Noile-Immune Biotech Company Details
11.13.2 Noile-Immune Biotech Business Overview
11.13.3 Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Introduction
11.13.4 Noile-Immune Biotech Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.13.5 Noile-Immune Biotech Recent Development
11.14 Novartis
11.14.1 Novartis Company Details
11.14.2 Novartis Business Overview
11.14.3 Novartis Chimeric Antigen Receptor T Cell Therapy Introduction
11.14.4 Novartis Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.14.5 Novartis Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Chimeric Antigen Receptor T Cell Therapy Introduction
11.15.4 Pfizer Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.15.5 Pfizer Recent Development
11.16 Sangamo Therapeutics
11.16.1 Sangamo Therapeutics Company Details
11.16.2 Sangamo Therapeutics Business Overview
11.16.3 Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Introduction
11.16.4 Sangamo Therapeutics Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.16.5 Sangamo Therapeutics Recent Development
11.17 Servier Laboratories
11.17.1 Servier Laboratories Company Details
11.17.2 Servier Laboratories Business Overview
11.17.3 Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Introduction
11.17.4 Servier Laboratories Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
11.17.5 Servier Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Allogeneic
Table 3. Key Players of Autologous
Table 4. Global Chimeric Antigen Receptor T Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Region (2020-2025)
Table 8. Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Region (2026-2031)
Table 10. Chimeric Antigen Receptor T Cell Therapy Market Trends
Table 11. Chimeric Antigen Receptor T Cell Therapy Market Drivers
Table 12. Chimeric Antigen Receptor T Cell Therapy Market Challenges
Table 13. Chimeric Antigen Receptor T Cell Therapy Market Restraints
Table 14. Global Chimeric Antigen Receptor T Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Players (2020-2025)
Table 16. Global Top Chimeric Antigen Receptor T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor T Cell Therapy as of 2024)
Table 17. Ranking of Global Top Chimeric Antigen Receptor T Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Chimeric Antigen Receptor T Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Chimeric Antigen Receptor T Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Chimeric Antigen Receptor T Cell Therapy, Product and Application
Table 21. Global Key Players of Chimeric Antigen Receptor T Cell Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Amgen Company Details
Table 47. Amgen Business Overview
Table 48. Amgen Chimeric Antigen Receptor T Cell Therapy Product
Table 49. Amgen Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 50. Amgen Recent Development
Table 51. Bellicum Pharmaceuticals Company Details
Table 52. Bellicum Pharmaceuticals Business Overview
Table 53. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Product
Table 54. Bellicum Pharmaceuticals Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 55. Bellicum Pharmaceuticals Recent Development
Table 56. Bluebird Bio Company Details
Table 57. Bluebird Bio Business Overview
Table 58. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Product
Table 59. Bluebird Bio Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 60. Bluebird Bio Recent Development
Table 61. Caribou Biosciences Company Details
Table 62. Caribou Biosciences Business Overview
Table 63. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Product
Table 64. Caribou Biosciences Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 65. Caribou Biosciences Recent Development
Table 66. Celgene Corporation Company Details
Table 67. Celgene Corporation Business Overview
Table 68. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Product
Table 69. Celgene Corporation Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 70. Celgene Corporation Recent Development
Table 71. Cellectis Company Details
Table 72. Cellectis Business Overview
Table 73. Cellectis Chimeric Antigen Receptor T Cell Therapy Product
Table 74. Cellectis Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 75. Cellectis Recent Development
Table 76. Celyad Oncology Company Details
Table 77. Celyad Oncology Business Overview
Table 78. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Product
Table 79. Celyad Oncology Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 80. Celyad Oncology Recent Development
Table 81. Gilead Sciences Company Details
Table 82. Gilead Sciences Business Overview
Table 83. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Product
Table 84. Gilead Sciences Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 85. Gilead Sciences Recent Development
Table 86. Intellia Therapeutics Company Details
Table 87. Intellia Therapeutics Business Overview
Table 88. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Product
Table 89. Intellia Therapeutics Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 90. Intellia Therapeutics Recent Development
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Product
Table 94. Johnson & Johnson Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 95. Johnson & Johnson Recent Development
Table 96. Legend Biotech Company Details
Table 97. Legend Biotech Business Overview
Table 98. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Product
Table 99. Legend Biotech Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 100. Legend Biotech Recent Development
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Chimeric Antigen Receptor T Cell Therapy Product
Table 104. Merck Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 105. Merck Recent Development
Table 106. Noile-Immune Biotech Company Details
Table 107. Noile-Immune Biotech Business Overview
Table 108. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Product
Table 109. Noile-Immune Biotech Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 110. Noile-Immune Biotech Recent Development
Table 111. Novartis Company Details
Table 112. Novartis Business Overview
Table 113. Novartis Chimeric Antigen Receptor T Cell Therapy Product
Table 114. Novartis Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 115. Novartis Recent Development
Table 116. Pfizer Company Details
Table 117. Pfizer Business Overview
Table 118. Pfizer Chimeric Antigen Receptor T Cell Therapy Product
Table 119. Pfizer Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 120. Pfizer Recent Development
Table 121. Sangamo Therapeutics Company Details
Table 122. Sangamo Therapeutics Business Overview
Table 123. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Product
Table 124. Sangamo Therapeutics Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 125. Sangamo Therapeutics Recent Development
Table 126. Servier Laboratories Company Details
Table 127. Servier Laboratories Business Overview
Table 128. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Product
Table 129. Servier Laboratories Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025) & (US$ Million)
Table 130. Servier Laboratories Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report


List of Figures
Figure 1. Chimeric Antigen Receptor T Cell Therapy Picture
Figure 2. Global Chimeric Antigen Receptor T Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. Allogeneic Features
Figure 5. Autologous Features
Figure 6. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Universities and Colleges Case Studies
Figure 10. Others Case Studies
Figure 11. Chimeric Antigen Receptor T Cell Therapy Report Years Considered
Figure 12. Global Chimeric Antigen Receptor T Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Chimeric Antigen Receptor T Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Players in 2024
Figure 16. Global Top Chimeric Antigen Receptor T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor T Cell Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor T Cell Therapy Revenue in 2024
Figure 18. North America Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Chimeric Antigen Receptor T Cell Therapy Market Share by Country (2020-2031)
Figure 20. United States Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Chimeric Antigen Receptor T Cell Therapy Market Share by Country (2020-2031)
Figure 24. Germany Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Share by Region (2020-2031)
Figure 32. China Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Chimeric Antigen Receptor T Cell Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Amgen Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 48. Bellicum Pharmaceuticals Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 49. Bluebird Bio Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 50. Caribou Biosciences Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 51. Celgene Corporation Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 52. Cellectis Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 53. Celyad Oncology Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 54. Gilead Sciences Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 55. Intellia Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 56. Johnson & Johnson Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 57. Legend Biotech Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 58. Merck Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 59. Noile-Immune Biotech Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 60. Novartis Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 61. Pfizer Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 62. Sangamo Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 63. Servier Laboratories Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies